2020년 2월 11일 09:58

OncoSec Announces Closing of the CGP/Sirtex Transaction

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, following shareholder approval, the proposed strategic investment by and partnershi...

2020년 2월 10일 12:57

온코섹, CGP/설텍스 거래에 대한 주주 승인 획득

후기 단계의 종양 내 암 면역요법을 개발하고 있는 온코섹 메디컬(OncoSec Medical Incorporated)(나스닥: ONCS)(이하 ‘회사’ 또는 ‘온코섹’)의 특별 주주총회에서 차이나 그랜드 파마슈티컬 앤 헬스케어 홀딩스(China Grand Pharmaceutical and Healthcare Holdings...

2020년 2월 10일 12:57

OncoSec Announces that Shareholders Have Approved CGP/Sirtex Transaction

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, at its Special Meeting of Shareholders (the “Special Meeting”), based on a prelimin...

2020년 2월 10일 11:40

OncoSec Announces that Nevada Court Denies Alpha Holdings’ Motion to Enjoin Special Meeting of Shareholders

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today commented on the February 6 ruling from the District Court in Clark County, Nevada, denying Alpha H...

2020년 2월 10일 11:38

온코섹 발표: 네바다 법원, 알파 홀딩스의 주주 특별총회 개최 금지 신청 기각

후기 단계 종양내 면역요법을 개발하고 있는 온코섹 메디컬(OncoSec Medical Incorporated)(나스닥: ONCS)(이하 ‘회사’ 또는 ‘온코섹’)이 차이나 그랜드 파마슈티컬 앤 헬스케어 홀딩스(China Grand Pharmaceutical and Healthcare Holdings Limited)의 완전 자회사...

2020년 2월 3일 08:55

OncoSec Urges Shareholders to Focus on the Critical Benefits of CGP/Sirtex Transaction

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today issued the following statement to its shareholders related to the upcoming Special Meeting to vote ...

2020년 1월 29일 09:22

OncoSec Urges Shareholders Not to Fall for Alpha’s Disingenuous “Proposal” and Scheme to Prevent Fair Vote at Special Meeting

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today issued the following statement to its shareholders regarding Alpha Holdings, Inc.’s (“Alpha”) Janua...

2020년 1월 22일 09:42

OncoSec Sends Letter Urging Shareholders Not to Be Distracted by Alpha’s Last-Ditch Efforts to Derail CGP/Sirtex Transaction

Daniel O’Connor, President, Director & CEO of OncoSec Medical Incorporated (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today sent the following letter to shareholders. The full text of the letter and additio...

2020년 1월 17일 08:44

OncoSec Board Rejects Alpha Holdings “Proposal” and Announces New Special Meeting Date

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that its Board of Directors (the “Board”) has determined the Alpha Holdings, Inc. (“Alph...

2020년 1월 7일 10:30

OncoSec Sends Letter to Shareholders Highlighting that Both Leading Independent Proxy Advisory Firms - ISS and Glass Lewis - Have Recommended That OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction on the WHITE Proxy Card

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today issued the following letter to its shareholders. The full text of the letter and additional inform...

2019년 12월 27일 09:41

Institutional Shareholder Services Inc. (“ISS”) Recommends OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that Institutional Shareholder Services Inc. (“ISS”), a leading proxy advisory firm that...

2019년 12월 23일 11:00

OncoSec Responds to Alpha’s “Proposal”

OncoSec Medical Incorporated (NASDAQ:ONCS), (the “Company” or “OncoSec”) today issued the following response to the latest press release from Alpha Holdings, Inc. (Alpha): “Throughout its campaign to stop OncoSec’s proposed strategic transaction (...

2019년 12월 23일 10:28

OncoSec Releases Presentation Spotlighting the Benefits of the Proposed CGP/Sirtex Transaction and Partnership

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced the release of a detailed presentation highlighting the Company’s strategic rationale - ...

2019년 12월 13일 13:47

OncoSec CEO Sends Letter to Fellow Shareholders

Daniel O’Connor, President, Director & CEO of OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today sent the following letter to shareholders. The full t...

2019년 12월 10일 11:48

온코섹, CGP/설텍스 전략적 투자 설명 동영상 배포… 주주 이익 창출 이유 강조

후기 종양 내 암 면역요법 개발사인 온코섹 메디컬 인코퍼레이티드(OncoSec Medical Incorporated, 이하 회사 또는 온코섹)(나스닥: ONCS)가 그랜드 파마슈티컬 앤 헬스케어 홀딩스 리미티드(China Grand Pharmaceutical and Healthcare Holdings Limited, 이하 CGP)...

2019년 12월 10일 11:45

OncoSec Releases Video Highlighting Why CGP/Sirtex Strategic Transaction Will Create Significant Shareholder Value

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, released a video featuring its President and Chief Executive Officer, Daniel J. O’Connor, discussing why...

2019년 12월 6일 11:12

온코섹, 알파홀딩스 제출 개정 예비 위임장 설명서의 문제 소지에 대한 입장 표명

온코섹 메디컬 인코퍼레이티드(OncoSec Medical Incorporated)(나스닥: ONCS)(이하 회사 또는 온코섹)가 2019년 12월 3일 알파홀딩스(Alpha Holdings, 이하 알파)가 제출한 개정 예비 위임장 설명서 내 문제의 소지가 있는 투표 계획에 대한 입장문을 발표했다. 해당...

2019년 12월 6일 11:06

OncoSec Comments on Disturbing Elements of Alpha Holdings’ Revised Preliminary Proxy Filing

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, issued a statement highlighting a troubling voting scheme buried in Alpha Holdings, Inc.’s (“Alpha”) rev...

2019년 12월 3일 10:24

OncoSec Sets the Record Straight on Alpha Holdings’ False and Misleading Statements

OncoSec Medical Incorporated (NASDAQ: ONCS), (the “Company” or “OncoSec”) a company developing late-stage intratumoral cancer immunotherapies, today issued the following letter to shareholders. The full text of the letter and additional informatio...